CN110514491A - The pre-treating method of organic pollutant in a kind of analysis urine sample - Google Patents

The pre-treating method of organic pollutant in a kind of analysis urine sample Download PDF

Info

Publication number
CN110514491A
CN110514491A CN201910711460.8A CN201910711460A CN110514491A CN 110514491 A CN110514491 A CN 110514491A CN 201910711460 A CN201910711460 A CN 201910711460A CN 110514491 A CN110514491 A CN 110514491A
Authority
CN
China
Prior art keywords
urine sample
treating method
organic pollutant
supernatant
urine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201910711460.8A
Other languages
Chinese (zh)
Inventor
黄周兵
李慧珍
熊晶晶
谭保祥
游静
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jinan University
University of Jinan
Original Assignee
Jinan University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jinan University filed Critical Jinan University
Priority to CN201910711460.8A priority Critical patent/CN110514491A/en
Publication of CN110514491A publication Critical patent/CN110514491A/en
Pending legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00Sampling; Preparing specimens for investigation
    • G01N1/28Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00Sampling; Preparing specimens for investigation
    • G01N1/28Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
    • G01N1/34Purifying; Cleaning

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

The invention belongs to urine detection technical fields, disclose a kind of pre-treating method for analyzing organic pollutant in urine sample.Specifically includes the following steps: (1) reacts to obtain pretreated urine sample after mixing urine, rate of recovery indicant, ethyl sodium buffer solution with GRD beta-glucuronidase;(2) urine sample obtained by acetone and step (1) is mixed to occurring precipitating and solution becomes colorless state;(3) desiccant is added in step (2) described solution to continues to mix, separates solid sediment, takes supernatant A;Then acetone is added in obtained solid sediment to continues to mix, supernatant B is taken after filtering, then supernatant A and supernatant B are mixed.The present invention can analyze the organic pollutants such as nicotinic insecticide anabasine, Fipronil, carbamate and its metabolite in urine simultaneously, and when spiked levels are 2~100 μ g/L, the rate of recovery is 69.1 ± 1.1%~114.9 ± 6.2%.

Description

The pre-treating method of organic pollutant in a kind of analysis urine sample
Technical field
The invention belongs to urine detection technical field, in particular to the preceding place of organic pollutant in a kind of analysis urine sample Reason method.
Background technique
With the development of industrial society, problem of environmental pollution becomes increasingly conspicuous, and people's health requirement also increases day by day.Ring Pollutant in border can be through breathing, skin contact, and the approach such as drinking-water and food intake enter human body.The overwhelming majority enters human body Organic contamination in different forms or can measure discharge in urine, from parent to metabolin, from a small quantity to almost all.This Outside, urine specimen is easier to acquire than the other biologicals material such as blood or tissue.Therefore small organic molecule is that one kind has in urine The biomarker of reaction human body exposure in environmental pollution of future.In order to show that pollutant is overall sudden and violent in crowd Dewiness condition first has to carry out comprehensive screening to the pollutant in urine, now with the development of instrument analysis, may be implemented substantially Simultaneously to the analysis detection of multiple pollutant, however solid phase extraction is used for urine sample pre-treatment, and the operating time is long, cost Height, the matrix such as extraction efficiency and removal urinary pigment are limited, these factors hinder the efficiency of entire analyte detection process.Therefore, have Necessity develops new sample-pretreating method, and to meet simultaneously quickly, low cost is suitable for Some Organic Pollutants and metabolin Sample-pretreating method.
Summary of the invention
In order to overcome the shortcomings and deficiencies of the prior art described above, the purpose of the present invention is to provide a kind of analysis urine samples The pre-treating method of middle organic pollutant.
The purpose of the present invention is realized by following proposal:
The pre-treating method of organic pollutant in a kind of analysis urine sample, specifically includes the following steps:
(1) it is reacted after mixing urine, rate of recovery indicant, ethyl sodium buffer solution with GRD beta-glucuronidase To pretreated urine sample;
(2) urine sample obtained by acetone and step (1) is mixed to occurring precipitating and solution becomes colorless state;
(3) desiccant is added in step (2) described solution to continues to mix, separates solid sediment, takes supernatant A;So Acetone is added in obtained solid sediment afterwards to continues to mix, supernatant B is taken after filtering, then supernatant A and supernatant B are mixed It closes, obtains premenstrual treated urine sample.
Step (1) rate of recovery indicant is Acetamiprid-d3, the spiked levels in urine are 2~100 μ g/L.
The concentration of step (1) the ethyl sodium buffer solution is 0.2~2M, and pH is 5.0~5.4;Preferably, concentration For 1M, pH=5.2.
The concentration of step (1) described GRD beta-glucuronidase is 200,00~200,000U/mL, preferably 100,000U/ mL。
The volume ratio of step (1) urine, ethyl sodium buffer solution and GRD beta-glucuronidase be 0.5~ 4mL:0.05~0.4mL:15~50 μ L, the μ of preferably 1~2mL:0.1~0.2mL:15~50 L.
Step (1) it is described reaction at 25~50 DEG C reaction 8~for 24 hours, 12 h are preferably reacted at 37 DEG C.
The volume ratio of step (2) acetone and urine sample is 5~20:1;Preferably 8~15:1;
Step (3) desiccant is at least one of magnesium sulfate, sodium sulphate and calcium chloride.
The mass ratio of step (3) desiccant and step (2) described urine sample is 1~3:1;More preferably 1.5~2: 1。
The mass volume ratio of step (3) desiccant and acetone is 2g:2~10mL;Preferably 2g:4~7mL.
Step (3) is described supernatant A and supernatant B are mixed after, further include that nitrogen blows constant volume step;Preferably, the nitrogen Blowing constant volume is to be settled to 0.1~1.5mL.
Mixing for the first time described in step (2) and step (3), second of mixing and third time mixing independently are ultrasound 5 ~30min, preferably 10min.
Preferably, the organic pollutant in urine sample of the present invention is imidacloprid, chlordene niacin, imidacloprid-guanidine salt At least one of hydrochlorate, imidacloprid-urea, Fipronil, fluorine formonitrile HCN, Fipronil sulfone and Fipronil sulfoxide.
The present invention compared with the existing technology, have the following advantages and the utility model has the advantages that
1) present invention makes the Stromal Precipitations such as urinary pigment and albumen in urine using acetone, and the method for opposite Solid Phase Extraction operates More easy, cost is lower.
2) present invention can analyze organic dirt such as nicotinic insecticide anabasine, Fipronil, carbamate in urine simultaneously Object and its metabolite are contaminated, when spiked levels are 2~100 μ g/L, the rate of recovery is 69.1 ± 1.1%~114.9 ± 6.2%.
Detailed description of the invention
Fig. 1 is analyte rate of recovery figure when spiked levels are 2 μ g/L in embodiment 1.
Fig. 2 is analyte rate of recovery figure when spiked levels are 20 μ g/L in embodiment 1.
Fig. 3 is analyte rate of recovery figure when spiked levels are 100 μ g/L in embodiment 1.
Fig. 4 is spiked levels when being 2ppb, and this method and commercialization HLB carry out the rate of recovery comparison of pre-treatment to urine sample Figure.
Specific embodiment
Below with reference to embodiment and attached drawing, the present invention is described in further detail, but embodiments of the present invention are unlimited In this.
Agents useful for same can routinely be bought unless otherwise specified from market in embodiment.
1 urine anabasine of embodiment, the measurement of fipronil insecticide and its metabolin recovery of standard addition
By imidacloprid, chlordene niacin, imidacloprid-guanidine hydrochloride, imidacloprid-urea, Fipronil, fluorine formonitrile HCN, Fipronil sulfone With 2 μ g/L, 20 μ g/L and 100 μ g/L concentration, in synthetic urine, (purchase is in LEAGENE, number CZ0350- with Fipronil sulfoxide Mark-on is carried out in 500mL), to verify this method low, in, the rate of recovery under high concentration.Three parts of Duplicate Samples, concrete operation step It is as follows:
Synthetic urine 1.0mL is taken, rate of recovery indicant (Acetamiprid-d is added3, target in concentration and rate of recovery experiment is added Analyte is identical), 0.1mL acetic acid-sodium acetate buffer solution (1M, pH=5.2) and 15 μ L GRD beta-glucuronidases are added (100,000U/mL), 37 degree of lower reaction 12h.Obtain pretreated urine sample.10mL acetone is added to pretreated urine In liquid, ultrasonic 10min, until solution precipitates, solution becomes achromaticity and clarification state.2.0g anhydrous slufuric acid is added into solution Magnesium continues ultrasound 10min.Centrifugation collects upper layer organic extract liquid, then adds 5mL acetone into magnesium sulfate, ultrasound 10min extract liquor will merge twice, and nitrogen blows constant volume to 1.0mL.Internal standard (imidacloprid-d is added4It is dense with 13C-15N Fipronil Degree is 2 μ g/L), 0.22 μm of organic system pin hole filter membrane is crossed, 5500 is surpassed using Shimadzu LC-30-AD and AB Sciex QTRAP High liquid chromatography mass spectrometer measures compound concentration.
Fig. 1 is analyte rate of recovery figure when spiked levels are 2 μ g/L in embodiment 1.Fig. 2 is spiked levels in embodiment 1 Analyte rate of recovery figure when for 20 μ g/L.Fig. 3 is analyte rate of recovery figure when spiked levels are 100 μ g/L in embodiment 1.Mark-on Test result show the rate of recovery of test analyte under different spiked levels 69.1 ± 1.1%~114.9 ± 6.2% it Between.
2 matrix effect of embodiment
It 1) is solvent respectively by imidacloprid, chlordene niacin, imidacloprid-guanidine hydrochloride, imidacloprid-urea, fluorine using pure methanol Worm nitrile, fluorine formonitrile HCN, Fipronil sulfone and Fipronil sulfoxide are configured to the series of standards solution that concentration is 0.02~50 μ g/L, internal standard Compound is imidacloprid-d4With 13C-15N Fipronil, concentration is 2 μ g/L.
2) as the methanol solution of matrix to be solvent through treated the artificial urine of embodiment 1, respectively by imidacloprid, chlordene Niacin, imidacloprid-guanidine hydrochloride, imidacloprid-urea, Fipronil, fluorine formonitrile HCN, Fipronil sulfone and Fipronil sulfoxide are configured to concentration For the series of standards solution of 0.02~50 μ g/L, internal standard compound is imidacloprid-d4, concentration is 2 μ g/L.
3) it is obtained using 5500 superelevation liquid chromatography mass combined instrument of Shimadzu LC-30-AD and AB Sciex QTRAP above-mentioned The standard curve of two each target compounds of class series standard solution.
4) matrix effect (matrix effect, ME) of each target compound is calculated by formula (2).
ME=(Km-Ks)/Ks
KmIt is target compound as the methanol solution of matrix to be its in solvent through treated the artificial urine of embodiment 1 The slope of standard curve;KsFor the slope of target compound its standard curve in methanol solvate.
As a result: the matrix effect value of each test analyte is as shown in table 1.As known from Table 1, majority of compounds shows as base Matter weakens effect, and only Fipronil sulfone, Fipronil sulfoxide shows as matrix enhancement effect, and the matrix effect range of compound is- 40.76~25.68%.
Each analyte matrix effect value of table 1
Comparative example 1
The specific steps of HLB progress sample pre-treatments: (1) by urine, rate of recovery indicant, ethyl sodium buffer solution (add in substance additional amount and concentration and embodiment 1 with react to obtain pretreated urine sample after GRD beta-glucuronidase mixing It marks identical when concentration is 2 μ g/L);(2) take the solid-phase extraction column (60mg, 3mL) equipped with HLB filler in solid-phase extraction device, Extraction column is activated with 3mL methanol and 5mL ultrapure water respectively.(3) the pretreated urine sample for obtaining step (1) adds Be downloaded to it is activated after solid-phase extraction column in.(4) solid-phase extraction column in step (3) is eluted with 5mL methanol.Nitrogen blows concentration To 1mL.
Fig. 4 is spiked levels when being 2ppb, and this method and commercialization HLB carry out the rate of recovery comparison of pre-treatment to urine sample Figure.The rate of recovery of analyte is wanted figure 4, it is seen that this research method is able to satisfy with commercialization HLB solid-phase extraction column It asks.But pre-treatment is carried out to urine sample with this method, relative standard deviation (RSD%) is relative to HLB solid phase between Duplicate Samples Extraction is smaller, i.e., this method has better stability than solid phase extraction.In addition, this method is easy to operate, quickly, it is not necessarily to Using solid-phase extraction device and filler, can effectively save personnel's training on operation and material cost, improve the preceding place of urine sample Manage efficiency, the batch samples pre-treatment suitable for Some Organic Pollutants and metabolin.
The above embodiment is a preferred embodiment of the present invention, but embodiments of the present invention are not by above-described embodiment Limitation, other any changes, modifications, substitutions, combinations, simplifications made without departing from the spirit and principles of the present invention, It should be equivalent substitute mode, be included within the scope of the present invention.

Claims (10)

1. the pre-treating method of organic pollutant in a kind of analysis urine sample, which is characterized in that specifically includes the following steps:
(1) it reacts to obtain after mixing urine, rate of recovery indicant, ethyl sodium buffer solution with GRD beta-glucuronidase pre- Treated urine sample;
(2) urine sample obtained by acetone and step (1) is mixed to occurring precipitating and solution becomes colorless state;
(3) desiccant is added in step (2) described solution to continues to mix, separates solid sediment, takes supernatant A;Then exist Acetone is added in obtained solid sediment to continues to mix, supernatant B is taken after filtering, then supernatant A and supernatant B are mixed, obtained To premenstrual treated urine sample.
2. the pre-treating method of organic pollutant in analysis urine sample according to claim 1, it is characterised in that:
The concentration of step (1) the ethyl sodium buffer solution is 0.2~2M, and pH is 5.0~5.4;
The concentration of step (1) described GRD beta-glucuronidase is 200,00~200,000U/mL;
Step (1) rate of recovery indicant is Acetamiprid-d3, the spiked levels in urine are 2~100 μ g/L.
3. the pre-treating method of organic pollutant in analysis urine sample according to claim 1 or 2, it is characterised in that:
The volume ratio of step (1) urine, ethyl sodium buffer solution and GRD beta-glucuronidase is 0.5~4mL:0.05 The μ of~0.4mL:15~50 L.
4. the pre-treating method of organic pollutant in analysis urine sample according to claim 1 or 2, it is characterised in that: The volume ratio of step (2) acetone and urine sample is 5~20:1.
5. the pre-treating method of organic pollutant in analysis urine sample according to claim 1, it is characterised in that: step (3) desiccant is at least one of magnesium sulfate, sodium sulphate and calcium chloride.
6. the pre-treating method of organic pollutant in analysis urine sample according to claim 1, it is characterised in that:
The mass ratio of step (3) desiccant and step (2) described urine sample is 1~3:1;
The mass volume ratio of step (3) desiccant and acetone is 2g:2~10mL.
7. the pre-treating method of organic pollutant in analysis urine sample according to claim 1, it is characterised in that:
The mass ratio of step (3) desiccant and step (2) described urine sample is 1.5~2:1;
The mass volume ratio of step (3) desiccant and acetone is 2g:4~7mL.
8. the pre-treating method of organic pollutant in analysis urine sample according to claim 1, it is characterised in that: step (1) it is described reaction at 25~50 DEG C reaction 8~for 24 hours.
9. the pre-treating method of organic pollutant in analysis urine sample according to claim 1, it is characterised in that:
Step (3) is described supernatant A and supernatant B are mixed after, further include that nitrogen blows constant volume step;
Mixing for the first time described in step (2) and step (3), second mixing and third time mixing independently be ultrasound 5~ 30min。
10. the pre-treating method of organic pollutant in analysis urine sample according to claim 9, it is characterised in that:
It is to be settled to 0.1~1.5mL that step (3) described nitrogen, which blows constant volume,.
CN201910711460.8A 2019-08-02 2019-08-02 The pre-treating method of organic pollutant in a kind of analysis urine sample Pending CN110514491A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201910711460.8A CN110514491A (en) 2019-08-02 2019-08-02 The pre-treating method of organic pollutant in a kind of analysis urine sample

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201910711460.8A CN110514491A (en) 2019-08-02 2019-08-02 The pre-treating method of organic pollutant in a kind of analysis urine sample

Publications (1)

Publication Number Publication Date
CN110514491A true CN110514491A (en) 2019-11-29

Family

ID=68624221

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201910711460.8A Pending CN110514491A (en) 2019-08-02 2019-08-02 The pre-treating method of organic pollutant in a kind of analysis urine sample

Country Status (1)

Country Link
CN (1) CN110514491A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113009057A (en) * 2020-10-22 2021-06-22 重庆医科大学 Method for detecting neonicotinoid insecticides and metabolites in urine by solid phase extraction-ultra-high performance liquid chromatography-tandem mass spectrometry
CN114813991A (en) * 2022-03-09 2022-07-29 上海交通大学医学院 Method for detecting neonicotinoid insecticide in human urine

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106483230A (en) * 2016-03-16 2017-03-08 南方医科大学南方医院 A kind of method for quick of urine Hydroxyl Polycyclic Aromatic
CN108414631A (en) * 2018-02-08 2018-08-17 浙江省食品药品检验研究院 The detection method of 4 kinds of pesticide residues in a kind of spring bamboo
CN109507335A (en) * 2018-12-29 2019-03-22 上海交通大学医学院附属新华医院 Utilize the method for a variety of different type environmental contaminants in LC-MS-MS high throughput detection urine

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106483230A (en) * 2016-03-16 2017-03-08 南方医科大学南方医院 A kind of method for quick of urine Hydroxyl Polycyclic Aromatic
CN108414631A (en) * 2018-02-08 2018-08-17 浙江省食品药品检验研究院 The detection method of 4 kinds of pesticide residues in a kind of spring bamboo
CN109507335A (en) * 2018-12-29 2019-03-22 上海交通大学医学院附属新华医院 Utilize the method for a variety of different type environmental contaminants in LC-MS-MS high throughput detection urine

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
SEMIHOTLES著: "《食物成分与食品添加剂分析方法》", 31 August 2008 *
YAN TAO等: "Urinary monitoring of neonicotinoid imidacloprid exposure to pesticide applicators", 《SCIENCE OF THE TOTAL ENVIRONMENT》 *
张泽鸿主编: "《药学专业知识(一)考点精要》", 31 July 2011 *
李水军等主编: "《液相色谱-质谱联用技术临床应用》", 31 October 2014 *
胡彬等: "用柱切换HPLC测定其中痕量农药", 《药物分析杂志》 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113009057A (en) * 2020-10-22 2021-06-22 重庆医科大学 Method for detecting neonicotinoid insecticides and metabolites in urine by solid phase extraction-ultra-high performance liquid chromatography-tandem mass spectrometry
CN113009057B (en) * 2020-10-22 2023-11-07 重庆医科大学 Method for detecting neonicotinoid insecticides and metabolites in urine by solid phase extraction-ultra-high performance liquid chromatography-tandem mass spectrometry
CN114813991A (en) * 2022-03-09 2022-07-29 上海交通大学医学院 Method for detecting neonicotinoid insecticide in human urine

Similar Documents

Publication Publication Date Title
Ouyang et al. An ultra-facile and label-free immunoassay strategy for detection of copper (II) utilizing chemiluminescence self-enhancement of Cu (II)-ethylenediaminetetraacetate chelate
Divrikli et al. Determination of some trace metals in water and sediment samples by flame atomic absorption spectrometry after coprecipitation with cerium (IV) hydroxide
Shabani et al. On-line solid phase extraction system using 1, 10-phenanthroline immobilized on surfactant coated alumina for the flame atomic absorption spectrometric determination of copper and cadmium
CN110514491A (en) The pre-treating method of organic pollutant in a kind of analysis urine sample
Shao et al. Preparation of molecularly imprinted hybrid monoliths for the selective detection of fluoroquinolones in infant formula powders
Peralta et al. Solid phase extraction using nylon membranes with fluorescence detection as a fast and sensitive method for amiloride and furosemide determination in urine samples
CN104788560B (en) Ciclosporin A immunogene, anti-Ciclosporin A specific antibody and Ciclosporin A detection reagent
Jin et al. Determination of bromadiolone in whole blood by high-performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry
He et al. Facial synthesis of nickel (II)-immobilized carboxyl cotton chelator for purification of histidine-tagged proteins
Muñiz-Bustamante et al. Drugs of abuse in tap water from eight European countries: Determination by use of supramolecular solvents and tentative evaluation of risks to human health
CN104447984A (en) Docetaxel immunogen, anti-docetaxel specific antibody and docetaxel detection reagent
CN110045053A (en) A kind of QuEChERS pre-treating method of the analysis of the amphetamines suitable for blood
CN109336773A (en) A kind of preparation method and application of fluorescent optical sensor
JP2013541009A (en) Sample detection method
Wang et al. A polymeric solid-phase microextraction fiber for the detection of pharmaceuticals in water samples
CN105175531A (en) Hydroxyproline immunogen, specific antibody and detection reagent, and preparation methods thereof
Tzanavaras et al. Sequential injection method for the direct spectrophotometric determination of bismuth in pharmaceutical products
Pu et al. A novel deep eutectic solvent-based ultrasound-assisted dispersive liquid–liquid microextraction coupled with high-performance liquid chromatography for the determination of quinolones in environmental water samples
CN104774256B (en) Catecholamine immunogene, derivative and synthetic method, specific antibody and detection reagent and preparation method
CN112858690B (en) Urine albumin/urine creatinine composite quality control product and preparation method thereof
CN110133154A (en) The measuring method of perfluorochemical precursor substance in Atmospheric particulates sampling membrane
CN117783332A (en) Method for synchronously detecting multiple types of PPCPs in high-flux multiple matrixes
Wei et al. Preparation of MIL-101 (Cr)–NH2@ TAPB-DVA-COF based membrane solid-phase extraction for efficient enrichment and sensitive determination of trace aromatic disinfection by-products in juice drinks
Nakaya et al. Sensitive fluorimetric flow injection analysis for fluoride ion with a novel reagent, 2′, 7′-dichlorofluorescein di-tert-butyldimethylsilyl ether
CN108008033A (en) A kind of method for measuring water nitrite and nitrous acid content

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20191129